Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Condition: Degenerative Disc Disease · Sponsor: Mesoblast, Ltd.
About this study
The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (40)
| Axsendo Clinical Research/Summa Pain Care | Phoenix, Arizona, United States | — |
| Pain Institute of Southern Arizona | Tucson, Arizona, United States | — |
| TriWest Research Associates | Chula Vista, California, United States | — |
| Boomerang Health Care | Concord, California, United States | — |
| Apex Research Group | Fair Oaks, California, United States | — |
| Memorial Orthopaedic Surgical Group | Long Beach, California, United States | — |
| Newport Therapeutics | Newport Beach, California, United States | — |
| University of California-Davis Spine Center | Sacramento, California, United States | — |
| Innovative Pain Treatment Solutions | San Diego, California, United States | — |
| University of California-San Francisco | San Francisco, California, United States | — |
| Source Healthcare | Santa Monica, California, United States | — |
| Colorado Spine Partners/The Denver Spine and Pain Institute | Greenwood, Colorado, United States | — |
+ 28 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06325566